Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis
Author:
Patel Vaishali N.1, Knox Sarah M.1, Likar Karen M.12, Lathrop Colin A.1, Hossain Rydhwana1, Eftekhari Siavash1, Whitelock John M.3, Elkin Michael4, Vlodavsky Israel5, Hoffman Matthew P.1
Affiliation:
1. Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA. 2. Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, MD, USA. 3. School of Biomedical Engineering, University of New South Wales, Sydney,Australia. 4. Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem,Israel. 5. Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Abstract
Heparan sulfate proteoglycans are essential for biological processes regulated by fibroblast growth factors (FGFs). Heparan sulfate (HS) regulates the activity of FGFs by acting as a coreceptor at the cell surface, enhancing FGF-FGFR affinity, and being a storage reservoir for FGFs in the extracellular matrix (ECM). Here we demonstrate a critical role for heparanase during mouse submandibular gland (SMG) branching morphogenesis. Heparanase, an endoglycosidase, colocalized with perlecan in the basement membrane and in epithelial clefts of SMGs. Inhibition of heparanase activity in organ culture decreased branching morphogenesis, and this inhibition was rescued specifically by FGF10 and not by other FGFs. By contrast, exogenous heparanase increased SMG branching and MAPK signaling and, surprisingly, when isolated epithelia were cultured in a three-dimensional ECM with FGF10, it increased the number of lateral branches and end buds. In a solid-phase binding assay,an FGF10-FGFR2b complex was released from the ECM by heparanase. In addition,surface plasmon resonance (SPR) analysis showed that FGF10 and the FGF10-FGFR2b complex bound to purified perlecan HS and could be released by heparanase. We used the FGF10-FGFR2b complex as a probe for HS in SMGs, and it colocalized with perlecan in the basement membrane and partly colocalized with syndecan 1 in the epithelium, and binding was reduced by treatment with heparanase. In summary, our results show heparanase releases FGF10 from perlecan HS in the basement membrane, increasing MAPK signaling, epithelial clefting, and lateral branch formation, which results in increased branching morphogenesis.
Publisher
The Company of Biologists
Subject
Developmental Biology,Molecular Biology
Reference65 articles.
1. Abboud-Jarrous, G., Rangini-Guetta, Z., Aingorn, H., Atzmon, R.,Elgavish, S., Peretz, T. and Vlodavsky, I. (2005). Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J. Biol. Chem.280,13568-13575. 2. Allen, B. L. and Rapraeger, A. C. (2003). Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol.163,637-648. 3. Allen, B. L., Filla, M. S. and Rapraeger, A. C.(2001). Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J. Cell Biol.155,845-858. 4. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R. and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nat. Genet.23,354-358. 5. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994). Perlecan, basal lamina proteoglycan,promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell79,1005-1013.
Cited by
143 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|